Agilon Health (NYSE:AGL - Free Report) had its price objective lowered by Robert W. Baird from $5.00 to $1.00 in a research report report published on Thursday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the stock.
A number of other research firms also recently commented on AGL. Wells Fargo & Company cut their target price on shares of Agilon Health from $6.00 to $5.00 and set an "overweight" rating for the company in a research report on Tuesday, May 13th. Citigroup raised Agilon Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $3.25 to $5.00 in a report on Friday, April 25th. Evercore ISI reduced their price objective on Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a research report on Wednesday, July 9th. Benchmark dropped their target price on Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a research report on Wednesday, August 6th. Finally, The Goldman Sachs Group boosted their price target on Agilon Health from $2.50 to $5.00 and gave the company a "neutral" rating in a research note on Thursday, May 8th. Five research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $3.58.
View Our Latest Report on Agilon Health
Agilon Health Stock Up 1.2%
Shares of AGL stock traded up $0.0150 during mid-day trading on Thursday, hitting $1.2450. The company's stock had a trading volume of 7,972,083 shares, compared to its average volume of 21,522,348. Agilon Health has a 52-week low of $0.71 and a 52-week high of $6.08. The business has a 50-day moving average price of $1.94 and a 200 day moving average price of $3.04.
Agilon Health (NYSE:AGL - Get Free Report) last issued its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The business had revenue of $1.39 billion during the quarter, compared to analysts' expectations of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.Agilon Health's quarterly revenue was down 5.9% compared to the same quarter last year. During the same period last year, the firm posted ($0.07) EPS. Equities analysts forecast that Agilon Health will post -0.59 earnings per share for the current fiscal year.
Institutional Trading of Agilon Health
Institutional investors have recently made changes to their positions in the business. Capital International Investors boosted its stake in Agilon Health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after purchasing an additional 9,346,295 shares during the period. Millennium Management LLC grew its stake in Agilon Health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock valued at $13,704,000 after acquiring an additional 4,706,357 shares in the last quarter. Geode Capital Management LLC increased its holdings in Agilon Health by 2.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,156,466 shares of the company's stock valued at $16,462,000 after acquiring an additional 178,477 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in Agilon Health by 6.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company's stock valued at $21,911,000 after acquiring an additional 311,158 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in Agilon Health by 8.8% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,939,576 shares of the company's stock worth $21,388,000 after purchasing an additional 398,027 shares in the last quarter.
About Agilon Health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
